A Validation Study of a Point-of-Care Nerve Conduction Device for the Prediction of Chemotherapy-induced Peripheral Neurotoxicity
Not Applicable
- Conditions
- Those who have the possibility of developing chemotherapy-induced peripheral neurotoxicity
- Registration Number
- JPRN-UMIN000017868
- Lead Sponsor
- Department of Clinical Oncology and Chemotherapy, Nagoya University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with pre-existing neuropathy, such as diabetes mellitus, alcoholic abuse or central nervous system metastasis are excluded.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method